Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.
John A. Glaspy(UCLA Medical Center), Barbara Finck(Coherus BioSciences (United States)), Hong Tang(Coherus BioSciences (United States)), Paula G. O’Connor(Coherus BioSciences (United States))
Cited by 8
Related Papers
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733
Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial
|Arthritis & Rheumatism|2003|256
Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation
|Journal of Child Neurology|2000|244